What is Open Book Extracts?
Founded in 2018 and headquartered in Roxboro, North Carolina, Open Book Extracts operates as a cGMP-certified manufacturer specializing in premium plant-based cannabinoid ingredients. The company distinguishes itself through a vertically integrated supply chain, which allows for rigorous quality control from raw material sourcing to final product formulation. With a team led by Ph.D. chemists and seasoned industry veterans, the organization leverages a growing intellectual property portfolio to deliver high-purity extracts to a diverse client base. Beyond its domestic operations, the firm has established a strategic presence in Hong Kong through OBX Asia, facilitating international market access and providing localized support for its expanding global footprint.
How much funding has Open Book Extracts raised?
Open Book Extracts has raised a total of $11.5M across 1 funding round:
Series B
$11.5M
Series B (2021): $11.5M with participation from Nortecapital and KEY Investment Partners
Key Investors in Open Book Extracts
KEY Investment Partners
KEY Investment Partners is a U.S.-based private equity and venture capital firm focused on the cannabis industry. It invests in high-growth companies across the cannabis value chain, providing both capital and strategic guidance to help businesses scale in a rapidly evolving regulatory market.
Nortecapital
Nortecapital is an investment firm that provides strategic financial backing to emerging growth companies, often focusing on sectors requiring specialized operational expertise and infrastructure development.
What's next for Open Book Extracts?
Looking ahead, Open Book Extracts is well-positioned to capitalize on the increasing demand for transparency and standardization in the cannabinoid market. The current funding context suggests a strategic pivot toward further industrial scaling and the potential for deeper penetration into international markets. By leveraging its proprietary refinement methods and maintaining its commitment to cGMP standards, the company is likely to focus on diversifying its product pipeline and strengthening its IP moat. As the regulatory environment continues to evolve, the firm's ability to provide a reliable, compliant, and scalable supply chain will be the primary driver of its long-term competitive advantage and market leadership.
See full Open Book Extracts company page
